We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Phoqus | LSE:PQS | London | Ordinary Share | GB00B0M4CD64 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 8.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:6479R Phoqus Pharmaceuticals PLC 04 April 2008 Phoqus Pharmaceuticals plc Directors' share dealings West Malling, UK, 4 April 2008: Phoqus Pharmaceuticals plc (AIM: PQS) ("Phoqus" or the "Company"), the drug development company, announces that on 3 April 2008, Dr Peter Johnson, Chief Financial Officer of Phoqus, transferred 2,166 ordinary shares ("Shares") in the Company to an exercising option-holder in his capacity as nominee shareholder. Also, 2,912 Shares were transferred on the same date to a trust in which Dr Johnson is a potential beneficiary. As previously announced, share options granted by the Company on 3 November 2005 were to be satisfied by the transfer of Shares held by certain institutional shareholders. In order to facilitate the transfer of Shares to option-holders, some of the institutional shareholders transferred Shares to Dr Peter Johnson, Chief Financial Officer, to hold the Shares as their nominee pending exercise of the share options by the option-holders, after which he would transfer the relevant Shares to the exercising option-holders. Following the above transfer of 2,166 Shares to the exercising option-holders on 3 April 2008, 371 Shares are now held by Dr Johnson in his capacity as nominee, representing less than 0.01 per cent of the issued share capital of the Company. Separately, on 11 May 2006 a trust in which Dr Johnson is a potential beneficiary exercised options over Shares that had been granted to it by the Company on 3 November 2005. Due to the loss of a share certificate by the transferring institutional investor and subsequent administrative errors, 2,912 of the Shares were never formally transferred to the trust. The share certificate has now been replaced and the Shares were transferred to the trust on 3 April 2008. Dr Johnson's beneficial ownership of Phoqus Shares has therefore increased by 2,912 to 297,838 ordinary Shares, or 0.65 per cent of the issued share capital of the Company. Enquiries: Phoqus Pharmaceuticals plc Suzanne Smith, Company Secretary Tel: 01732 870227 Nomura Code Securities Limited Phil Walker Tel: 020 7776 1200 This information is provided by RNS The company news service from the London Stock Exchange END RDSEAFLLESKPEFE
1 Year Phoqus Chart |
1 Month Phoqus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions